Dr. Robert Wollman, MD
Claim this profileJohn Wayne Cancer Institute
Studies Ductal Carcinoma In Situ
Studies Ductal Carcinoma
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Robert Wollman, MD is currently running
7-Gene Biosignature
for Ductal Carcinoma
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
Recruiting1 award N/A7 criteria
Oncoplastic Surgery + IORT
for Breast Cancer
Prospective, Non-randomized, Single-arm.The objectives of this study are to evaluate cosmesis and perioperative complications associated with the use of intraoperative radiotherapy (IORT) at the time of partial mastectomy in patients with breast cancer and a prior history of radiation therapy. Secondary objectives include evaluating effectiveness of partial mastectomy with IORT, measured by local, regional and distant recurrence, mastectomy rate, and disease-specific and overall survival.
Recruiting1 award N/A9 criteria
More about Robert Wollman, MD
Clinical Trial Related7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Robert Wollman, MD has experience with
- DCISionRT Test
- Intraoperative Radiation Therapy (IORT)
- Intraoperative Radiotherapy
- Oncoplastic Partial Mastectomy
Breakdown of trials Robert Wollman, MD has run
Ductal Carcinoma In Situ
Ductal Carcinoma
Lobular Carcinoma in Situ
Breast Cancer
Intra-Operative Radiation Therapy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Wollman, MD specialize in?
Robert Wollman, MD focuses on Ductal Carcinoma In Situ and Ductal Carcinoma. In particular, much of their work with Ductal Carcinoma In Situ has involved treating patients, or patients who are undergoing treatment.
Is Robert Wollman, MD currently recruiting for clinical trials?
Yes, Robert Wollman, MD is currently recruiting for 3 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that Robert Wollman, MD has studied deeply?
Yes, Robert Wollman, MD has studied treatments such as DCISionRT Test, Intraoperative Radiation Therapy (IORT), Intraoperative Radiotherapy.
What is the best way to schedule an appointment with Robert Wollman, MD?
Apply for one of the trials that Robert Wollman, MD is conducting.
What is the office address of Robert Wollman, MD?
The office of Robert Wollman, MD is located at: John Wayne Cancer Institute, Santa Monica, California 90404 United States. This is the address for their practice at the John Wayne Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.